Recorded Presentation from the Molecular Testing in Non-Small Cell Lung Cancer Webinar Series - Best Practices in Molecular Testing in NSCLC

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Locally Advanced NSCLC: Stage IIIA Management

Join Ross Camidge, MD, PhD, Brian Kavanagh, MD, MPH, and Michael Weyant, MD, as they present their multidisciplinary expertise on a range of cases pertaining to Locally Advanced NSCL Cancer: Stage IIIA Managment.

Molecular Testing in Non-Small Cell Lung Cancer Webinar Series - Best Practices in Molecular Testing in NSCLC

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Management of Patients With Lung Cancer and Poor Performance Status

Patients who are able to care for themselves but are unable to perform most work-related activities are considered to have a poor performance status (PS). Individuals who fulfill these criteria constitute a significant proportion of all patients with lung cancer.

Recorded Presentation from the Molecular Testing in Non-Small Cell Lung Cancer Webinar Series - Patient Navigation: Role in Molecular Testing in NSCLC

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Recorded Presentation from the Molecular Testing in Non-Small Cell Lung Cancer Webinar Series - Appropriate Selection of Therapy in NSCLC Using Biomarker Data

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Recorded Presentation from the Molecular Testing in Non-Small Cell Lung Cancer Webinar Series - Evaluation and Workup of Patients with NSCLC

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Recorded Presentation from the Molecular Testing in Non-Small Cell Lung Cancer Webinar Series - Tissue Acquisition in NSCLC: Surgical and Interventional Radiology Perspectives

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Recorded Presentation from the Molecular Testing in Non-Small Cell Lung Cancer Webinar Series - Interdisciplinary Cooperation: A Model Tumor Board in Non-Small Cell Lung Cancer

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Locally Advanced NSCL Cancer: Stage IIIA Management

Join Ross Camidge, MD, PhD, Brian Kavanagh, MD, MPH, and Michael Weyant, MD, as they present their multidisciplinary expertise on a range of cases pertaining to Locally Advanced NSCL Cancer: Stage IIIA Managment.

Pages

Subscribe to RSS - Lung Cancers